Stephen B Tatter, M.D. Ph.D.

Affiliations: 
1978-1982 BS Cellular & Molecular Biology University of Michigan, Ann Arbor, Ann Arbor, MI 
 1982-1989 PhD Virology Laboratory Rockefeller University, New York, NY, United States 
 1982-1990 MD Biomedical Science Weill Cornell Medical College, New York, NY, United States 
 1990-1997 Neurosurgery Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States 
 1997- Neurosurgery Wake Forest University School of Medicine, Winston-Salem, NC, United States 
Area:
brain and pituitary tumors, image-guided neurosurgery, stereotactic radiosurgery, deep brain stimulation, trigeminal neuralgia, human brain catecholamine measurement
Website:
https://orcid.org/0000-0002-1063-0431
Google:
"Dr. Stephen B. Tatter"
Bio:

Primary laboratory and clinical research interest: image guidance to introduce therapeutic viruses, drugs, radiation, and devices into the human brain for treatment and study of brain and pituitary tumors, of movement disorders, trigeminal neuralgia, and of normal brain function related to reward-based learning, decision making, and attentional selection. Clinically busy neurosurgeon at the Wake Forest Baptist Medical Center in Winston-Salem, NC and Gamma Knife Co-director, Department of Neurosurgery, Wake Forest University School of Medicine.

Mean distance: (not calculated yet)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wen PY, Manzanera A, Duault C, et al. (2025) A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma. Neuro-Oncology
Horn AC, Kolahi Sohrabi A, Chan MD, et al. (2024) Gamma Knife radiosurgery for relapsing trigeminal neuralgia following microvascular decompression. Journal of Neurosurgery. 1-9
Smith EC, Mott BT, Douglas E, et al. (2024) Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities. Cancer Metastasis Reviews. 44: 10
Calafiore RL, Helis CA, Marcet P, et al. (2024) Fractionated radiotherapy with stereotactic radiosurgery boost controls gross disease in grade 2 meningioma. World Neurosurgery
Choi AR, D'Agostino RB, Farris MK, et al. (2024) Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Frontiers in Endocrinology. 15: 1364021
Rimkus TK, Carpenter RL, Sirkisoon S, et al. (2024) Editor's Note: Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Research. 84: 3310
Ressler HW, Cramer CK, Isom S, et al. (2024) Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomes. Clinical Neurology and Neurosurgery. 238: 108191
Sadibolova R, DiMarco EK, Jiang A, et al. (2024) Sub-second and multi-second dopamine dynamics underlie variability in human time perception. Medrxiv : the Preprint Server For Health Sciences
Sands LP, Jiang A, Liebenow B, et al. (2023) Subsecond fluctuations in extracellular dopamine encode reward and punishment prediction errors in humans. Science Advances. 9: eadi4927
Williams MM, Sohrabi AK, Kittel CA, et al. (2023) Delayed Imaging Changes 18 months or Longer after Stereotactic Radiosurgery for Brain Metastases: Necrosis or Progression. World Neurosurgery
See more...